Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.
BRANCHBURG – Korean pharmaceutical firm Celltrion has launched operations at the former Eli Lilly facilities on Imclone Drive ...
A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...
The Chosun Ilbo on MSN
Novo Nordisk aims to approach consumers like Amazon
Competition in the obesity treatment market has intensified, and it is rapidly shifting from being centered on pharmaceutical ...
The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...
Eli Lilly will buy autoimmune drug developer Ventyx Biosciences for $1.2 billion in cash, the companies said on Wednesday, ...
Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, today reported significant momentum with the ...
Shortly after securing a partnership with Sanofi, InduPro is linking up with Eli Lilly in efforts to discover new cancer ...
Privately-held Boston, USA-based Nimbus Therapeutics today announced it has entered into a multi-year research collaboration ...
Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable ...
Celltrion on Tuesday announced the official beginning of its new biopharmaceutical manufacturing plant in Branchburg, New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback